ArticleScientific reports2023

A novel retinoic acid drug, EYE-502, inhibits choroidal neovascularization by targeting endothelial cells and pericytes.

Yaming Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.